SG

Simon Guile

AA Astrazeneca Ab: 12 patents #60 of 1,971Top 4%
AL Astrazeneca Uk Limited: 3 patents #28 of 159Top 20%
Overall (All Time): #321,826 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
RE46276 Triazolo(4,5-D)pyrimidine compounds David Hardem, Anthony Ingall, Brian Springthorpe, Paul Willis 2017-01-17
8106073 Quinoline derivatives 057 Toby Thompson 2012-01-31
7964616 Compounds 679 Mark Richard Ebden 2011-06-21
7393854 Thienopyrimidinedinones and their use in modulation of autoimmune disease Anthony Ingall 2008-07-01
7384950 Thienopyrimidinediones and their use in the modulation of autoimmune disease Rachel Heulwen Reynolds, Anthony Ingall, Rukhsana Rasul, Martin Cooper 2008-06-10
7384951 Thienopyrimidinediones and their use in the modulation of autoimmune disease 2008-06-10
7345047 Substituted [1,2,3]triazolo[4,5-d]pyrimidines Barrie Martin 2008-03-18
7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis 2007-07-31
7064126 Compounds Martin Cooper, Anthony Ingall, Rukhsana Rasul 2006-06-20
7034032 Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds Roger Brown, Garry Pairaudeau, Brian Springthorpe 2006-04-25
6974868 Compounds David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis 2005-12-13
6844348 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds Barrie Martin 2005-01-18
6713483 [1,2,3]-triazolo[4,5-d] pyrimidine compounds Brian Springthorpe 2004-03-30
6525060 Triazolo(4,5-d)pyrimidine compounds David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis 2003-02-25
6251910 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists Anthony Ingall, Brian Springthorpe, Paul Willis 2001-06-26